According to a recent study, a novel nanoparticle-based drug repaired neurons and improved microvasculature in a mouse model of spinocerebellar ataxia 1, a degenerative disease that affects the cerebellum.
Abnormal activation of a small population of neurons may contribute to motor learning and motor function deficits in patients with Parkinson’s disease, according to a recent study.
Northwestern investigators are exploring the potential of bacterial toxins to be turned into therapeutic agents to effectively ward off disease.
According to a recent study, Northwestern scientists have pinpointed how an ectoenzyme called CD73 undermines the effectiveness of an emerging cancer therapy.
A Northwestern Medicine study has demonstrated the role of dopamine in the progression of glioblastoma and suggests that targeting the neurotransmitter may slow cancer growth.
According to a recent study, significant changes or drops in income can increase the risk of cardiovascular disease, suggesting people in those situations should be a priority for interventions such as screenings.
A genome-wide analysis revealed nine new genes associated with fragile X syndrome, findings that shed light on the complex hereditary mechanisms behind the genetic disease.
A Northwestern Medicine study provides new insights into a signaling pathway in metastatic prostate cancer and suggests that a novel drug combination may improve treatment response and slow cancer growth.
Northwestern Medicine scientists demonstrated how innate immune cells in inflamed tissue induce DNA damage that promotes the development of cancer.
Kelly Wun, a fourth-year medical student, was the first author of a study that links the microbiome to the development of restenosis, the renarrowing of arteries after a procedure.